ArticleClinical and experimental nephrology2026
Effects of low-phosphate boiled-meat meal on CKD-MBD and inflammatory indicators in maintenance hemodialysis patients with controlled calcium carbonate dosing.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated whether low-phosphate boiled-meat meals (LP meals), provided together with a fixed minimal dose of calcium carbonate (CaCO
methodsParticipants completed an adaptation diet followed by 7 days of LP meals or standard control meals. Both groups received an identical minimal dose of CaCO
resultsForty patients completed the study (LP group, n = 20; control group, n = 20). Serum phosphate levels increased significantly in the control group after the intervention but remained stable in the LP group (2nd 6.61 ± 2.04 mg/dL vs. 1st 5.61 ± 1.14 mg/dL; P < 0.05). Reductions in tumor necrosis factor-α and serum calcium from baseline were significantly greater in the LP group than in the control group (both P < 0.05).
conclusionThe LP meals, when consumed with a controlled, minimal CaCO3 dose, helped prevent increases in blood phosphate, hypercalcemia, and inflammation compared with standard meals that received the same binder dose.
Indexed as
Identifiers
41817903What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.